Literature DB >> 15242340

Transcriptional activation by nuclear receptors.

Mari Luz Acevedo1, W Lee Kraus.   

Abstract

Transcriptional activation by nuclear receptors (NRs) involves the recruitment of distinct classes of co-activators and other transcription-related factors to target promoters in the chromatin environment of the nucleus. Chromatin has a general repressive effect on transcription, but also provides opportunities for NRs to regulate transcription by directing specific patterns of chromatin remodelling and histone modification. Ultimately, the transcription of hormone-regulated genes by NRs is critically dependent on co-ordinated physical and functional interactions among the receptors, chromatin, co-activators with chromatin-, histone- and factor-modifying activities, and the RNA polymerase II transcriptional machinery. In addition, several mechanisms exist to terminate or attenuate NR-dependent signalling, including modification, recycling, subcellular redistribution and degradation of the receptors or their associated cofactors. The complexity of NR-dependent transcription provides multiple targets for regulatory inputs, thus allowing each hormone-responsive cell to direct its transcriptional output in a physiologically appropriate manner.

Mesh:

Substances:

Year:  2004        PMID: 15242340     DOI: 10.1042/bse0400073

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  21 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

3.  Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.

Authors:  Edwin Cheung; Mari Luz Acevedo; Philip A Cole; W Lee Kraus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

Review 4.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 5.  Nuclear receptors and chromatin remodeling machinery.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Mol Cell Endocrinol       Date:  2007-01-19       Impact factor: 4.102

6.  Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.

Authors:  Adarsh J Sai; J Christopher Gallagher; Xiang Fang
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

7.  Steroid hormone receptors silence genes by a chromatin-targeted mechanism similar to those used for gene activation.

Authors:  A Silvina Nacht; Miguel Beato; Guillermo P Vicent
Journal:  Transcription       Date:  2016-10-04

8.  Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.

Authors:  Miao Sun; Gary D Isaacs; Nasun Hah; Nina Heldring; Elizabeth A Fogarty; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2012-03-22

9.  ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.

Authors:  June X Zou; Alexey S Revenko; Li B Li; Abigael T Gemo; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-12       Impact factor: 11.205

10.  Structure, affinity, and availability of estrogen receptor complexes in the cellular environment.

Authors:  Eric M Kofoed; Martin Guerbadot; Fred Schaufele
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.